50,000 people taking part in phase 3 trial of Chinese COVID-19 Vaccine
Sep 05, 2020
Beijing [China], August 05 (ANI/Sputnik): Around 50,000 people in a number of countries are participating in phase 3 clinical trials of a coronavirus vaccine developed by the China National Biotec Group (CNBG), the company said on Saturday in a press release.